Carlisle Companies News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.09.24	ECB hawk sees room for more interest rate cuts (Financial Times)
12.09.24	Top Russian Foreign Policy Hawk Pushes For Bold Nuclear Response To Western Support In Ukraine: 'Time To Declare That We Have The Right To Respond' (Benzinga)
26.07.24	$100 Invested In Carlisle Companies 5 Years Ago Would Be Worth This Much Today (Benzinga)
24.07.24	Carlisle Companies Inc. Q2 Profit Increases, Beats Estimates (RTTNews)
23.07.24	Ausblick: Carlisle Companies gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
15.07.24	Analyst Scoreboard: 4 Ratings For Carlisle Companies (Benzinga)
28.06.24	GE Aerospace Delivers T901 Engines To US Army For Black Hawk Testing: Details (Benzinga)
17.05.24	Here's How Much $100 Invested In Carlisle Companies 5 Years Ago Would Be Worth Today (Benzinga)
10.05.24	Kashkari Vs. Goolsbee, Hawk Vs. Dove: What's Next For The Fed? (Benzinga)
01.05.24	Carlisle Companies To Expand Research And Innovation Center In Carlisle, Pennsylvania (RTTNews)
25.04.24	Carlisle Companies Inc. Q1 Profit Increases, beats estimates (RTTNews)
24.04.24	Ausblick: Carlisle Companies informiert über die jüngsten Quartalsergebnisse (finanzen.net)
06.02.24	Carlisle Companies Inc. Q4 Profit Increases, beats estimates (RTTNews)
05.02.24	Ausblick: Carlisle Companies stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
30.01.24	Amphenol To Buy CIT Business From Carlisle In $2.025 Bln Cash Deal (RTTNews)
21.12.23	CSL and Arcturus Therapeutics' ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster (PR Newswire)
14.12.23	CSL's Garadacimab, a First-in-Class Factor XIIa Inhibitor, Receives FDA and EMA Filing Acceptance (PR Newswire)
12.12.23	CSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates at Three Years Post-Treatment Long-Term Durability, Safety and Greater Bleed Protection Versus Prophylactic Treatment in Peopl... (PR Newswire)
07.12.23	Carlisle Companies Announces Vision 2030 Strategy (RTTNews)
28.11.23	Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults (PR Newswire)
24.11.23	Iron Deficiency Day 2023: CSL Vifor calls for access to iron deficiency diagnosis and treatment (PR Newswire)
27.10.23	CSL and uniQure Win 2023 Prix Galien USA Award (PR Newswire)
26.10.23	Carlisle Companies Inc. Q3 Profit Increases, beats estimates (RTTNews)
25.10.23	Ausblick: Carlisle Companies stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
11.10.23	New Data Presented at IDWeek 2023 Demonstrates Public Health Benefit and Cost Savings Associated with Cell-Based and Adjuvanted Influenza Vaccines (PR Newswire)
19.09.23	CSL Seqirus Presents Real-World Evidence at ESWI Demonstrating the Impact of Influenza Vaccination Campaigns to Help Protect People and Healthcare Systems (PR Newswire)
28.08.23	CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine (PR Newswire)
28.08.23	Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines (PR Newswire)
17.08.23	CSL Appoints Jeffrey Ball as First Chief Sustainability Officer (PR Newswire)
26.07.23	Carlisle Companies Inc. Q2 Profit Decreases, but beats estimates (RTTNews)
25.07.23	Ausblick: Carlisle Companies mit Zahlen zum abgelaufenen Quartal (finanzen.net)
17.07.23	CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2023/24 U.S. Season (PR Newswire)
20.06.23	CSL Behring Announces the First Patient Has Received FDA-Approved HEMGENIX® (etranacogene dezaparvovec-drlb) for Hemophilia B (PR Newswire)
15.06.23	Carlisle To Sell Carlisle Fluid Technologies - Quick Facts (RTTNews)
05.06.23	Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure (PR Newswire)
18.05.23	Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus (PR Newswire)
02.05.23	Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis (PR Newswire)
27.04.23	Carlisle Companies Inc. Q1 Profit Decreases, misses estimates (RTTNews)
26.04.23	Ausblick: Carlisle Companies zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
18.04.23	CSL Behring Receives FDA Approval for Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) 50mL Prefilled Syringe (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	25.43	0.08 %	K V
Nestle	88.15	-0.01 %	K V
Zurich Insur Gr	593.20	-0.07 %	K V
Logitech Intl	63.36	-0.13 %	K V
Swiss Life Hldg	842.80	-0.38 %	K V
CieFinRichemont	143.15	-1.82 %	K V
Roche Hldg G	266.20	-1.92 %	K V
Part Grp Hldg	1’073.00	-2.14 %	K V
Lonza Grp	577.80	-2.50 %	K V
Kuehne+Nagel Int	182.75	-2.77 %	K V

Carlisle Companies Aktie VALOR 916251 / ISIN US1423391002

Nachrichten zu Carlisle Companies Inc.

Aktien Top/Flop

Meistgelesene Nachrichten